Eli Lilly's Oral GLP-1 Breakthrough Could Change Everything

Eli Lilly and Company TodayLLYEli Lilly and Company$761.52 +1.39 (+0.18%) 52-Week Range$623.78▼$939.86Dividend Yield0.79%P/E Ratio49.79Price Target$939.61Add to WatchlistEli Lilly and Company NYSE: LLY has been one of the best-performing stocks outside of the AI-enhanced Magnificent 7 stocks over the past 12 months. The company is the leader in the GLP-1 market, which is transforming the management of type 2 diabetes and the obesity market. LLY stock is up 10% in the last month on news that the U.S. Food & ...